FDA OKs Merck drug that prevents infection post-stem cell transplant Ruby Khatun Khatun11 Nov 2017 10:01 AM ISTMerck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
Dynavax hepatitis B vaccine gets FDA nod on third try, shares up Ruby Khatun Khatun11 Nov 2017 9:45 AM ISTDynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 9:30 AM ISTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
Granules India posts Q2 net profit at Rs 40 crore Ruby Khatun Khatun10 Nov 2017 10:47 AM ISTNew Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current...
Piramal group expands healthcare project ASARA Ruby Khatun Khatun10 Nov 2017 10:31 AM ISTVishakhapatnam: Piramal Swasthya, an initiative under the aegis of Piramal Foundation (the philanthropic arm of the Piramal Group), announced the...
Novartis takes fight to Pfizers Ibrance with new Kisqali data Ruby Khatun Khatun10 Nov 2017 10:17 AM ISTZURICH: New data from Novartis's breast cancer drug Kisqali underscored its effectiveness in pre-menopausal women, the Swiss drugmaker said, amid...
GSK appoints scientist Barron as new Research and Development head Ruby Khatun Khatun10 Nov 2017 9:47 AM ISTLONDON: GlaxoSmithKline (GSK) has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief...
Thousands of drugs at risk if no Brexit deal, companies warn Ruby Khatun Khatun10 Nov 2017 9:30 AM ISTSupplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, European pharmaceutical...
Mylan seeks EMA approval for 2 biosimilars Ruby Khatun Khatun9 Nov 2017 10:32 AM ISTNew Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore Ruby Khatun Khatun9 Nov 2017 10:16 AM ISTNew Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
FDA clears common blood cell count test that offers faster results for patients and providers Ruby Khatun Khatun9 Nov 2017 9:49 AM ISTThe U.S. Food and Drug Administration (FDA) cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 9:37 AM ISTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...